Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
A$ 0.45
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a research collaboration agreement with Monash University to screen known...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Data is available to registered users only
Target Price
The average target price of ILA.AX is 0.53 and suggests 12% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio
Data is available to registered users only
Buy
Sell